drugset / Trial / NCT00293592

Dexamethasone for Cardiac Surgery Trial

NCT00293592 ↗

Completed 4500 enrolled UMC Utrecht
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multicenter, randomized, double-blind trial, comparing clinical outcomes after the administration of high-dose dexamethasone versus placebo in patients undergoing heart surgery with the use of cardiopulmonary bypass. The primary endpoint is the occurrence of major complications (including all-cause mortality, myocardial infarction, stroke, renal failure, and prolonged mechanical ventilation) in the first 30 days after surgery.

Timeline

Start
2006-05
Primary completion
2011-11
Completion
2012-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 1 mg/kg Intravenous